Deepika Polineni, M.D., M.P.H.

Associate Professor of Medicine
University of Kansas Medical Center, Kansas City, KS, USA

Poster(s):

• (28) A MULTI-CENTER STUDY of PERIPHERALLY INSERTED CENTRAL VENOUS CATHETERS (PICC-CF): PREDICTORS of DIFFICULT LINE INSERTION, MALFUNCTION and SOFT TISSUE INJURY
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (168) Results from APPLAUD Phase 2 Study with Pro-Resolution Drug Candidate LAU-7b in Adults with Cystic Fibrosis
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (170) Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from an open-label extension study
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (185) Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating or residual function mutation
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (289) Training CF care team members to deliver a behavioral telehealth intervention to improve adherence in adolescents and young adults with CF
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (312) Barriers to sustaining daily care in adults with CF with mild depression and anxiety
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (576) Safety of Non-cuffed Tunneled Small-bore Central Venous Catheters in Adults with Cystic Fibrosis
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET